It feels like there’s never been a better time to go through menopause, thanks to new treatment options and growing research in this space. You may have heard about Veozah, the FDA-approved non-hormonal prescription pill that can help ease hot flashes and night sweats. As it turns out, Veozah may do even more than originally advertised.
While data show that Veozah can lower the number and severity of hot flashes, new data suggests the drug was also linked to improved symptoms of depression and anxiety, too.
A study on Veozah called OPTION-VMS found that the drug was linked to statistically significant improvements in anxiety and depression symptoms, suggesting this medication may have benefits that extend beyond hot flash relief. Here’s what menopause experts want you to know.
What did the study find?
The OPTION-VMS study is ongoing, but preliminary results were recently presented at the Endocrine Society’s annual meeting. For the observational study, researchers followed 656 women between the ages of 40 and 75 with hot flashes who were prescribed medications like fezolinetant (Veozah), common antidepressants like SSRIs or SNRIs, the anticonvulsant medication gabapentin, and oxybutynin—all of which are currently used or have been used in the past to treat hot flashes.
Read Full Article Here
